Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can weightlifting beat cardio for blood sugar in pregnancy?

NCT ID NCT07802262

Disease control Sponsor: University of Central Arkansas Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests whether the type and intensity of exercise affect blood sugar control in pregnant women with gestational diabetes. Participants will complete four separate exercise sessions: low-intensity resistance training, low-intensity aerobic training, moderate-intensity resistance training, and moderate-intensity aerobic training. Researchers will monitor blood glucose continuously during and for 24 hours after each session, and also measure insulin sensitivity before and after. The goal is to see if resistance training or moderate intensity offers better glucose regulation than aerobic training or low intensity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acute exercise sessions comparing resistance training (weightlifting) and aerobic training (cardio) at low and moderate intensities
What this could lead to
If it works, this could point toward specific exercise prescriptions that help pregnant women with gestational diabetes manage blood sugar and insulin sensitivity.
What could go wrong
This is a small, early study with only 23 participants, and it tests single exercise sessions rather than a full program, so the results may not translate to long-term glucose control or apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 23 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Biological female * Singleton (one fetus) * 24-30-wks gestation * 18-35 yrs old * Sedentary * Conception without the use of assisted fertility treatments Exclusion Criteria: * Existing other metabolic disorders * Currently taking medication or supplements that affect glucose metabolism * Taking drugs, tobacco, or alcohol during pregnancy * Having a contraindication to exercise

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gestational diabetes mellitus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes Insulin Resistance Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gestational diabetes mellitus Gestational diabetes mellitus in pregnancy Insulin resistance

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Human Performance Laboratory (HPL) at the University of Central Arkansas

    RECRUITING

    Conway, Arkansas, 72035, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.